KARYOPHARM THERAPEUTICS INC

CUSIP: 48576U106 Class: Common Stock

MARSHALL WACE, LLP's Holding History (CIK: 0001318757)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024
Shares 2,401,413 Value ($000) $1,633 Avg Close — Range —
Q3 2024
Shares 2,082,226 Value ($000) $1,728 Avg Close — Range —
Q2 2024
Shares 2,580,863 Value ($000) $2,245 Avg Close — Range —
Q1 2024
Shares 2,595,599 Value ($000) $3,919 Avg Close — Range —
Q4 2023
Shares 1,926,782 Value ($000) $1,657 Avg Close — Range —
Q3 2023
Shares 2,183,201 Value ($000) $2,925 Avg Close — Range —
Q2 2023
Shares 2,443,997 Value ($000) $4,375 Avg Close — Range —
Q1 2023
Shares 1,984,906 Value ($000) $7,721 Avg Close — Range —
Q4 2022
Shares 2,210,223 Value ($000) $7,515 Avg Close — Range —
Q3 2022
Shares 159,137 Value ($000) $868 Avg Close — Range —
Q2 2022
Shares 23,000 Value ($000) $103 Avg Close — Range —
Q4 2021
Shares 9,006 Value ($000) $57 Avg Close — Range —
Q4 2020
Shares 217,430 Value ($000) $3,366 Avg Close — Range —
Q3 2020
Shares 18,845 Value ($000) $275 Avg Close — Range —
Q4 2019
Shares 294,512 Value ($000) $5,645 Avg Close — Range —